News

An age-stratified analysis of endothelial cell count in diabetic and non-diabetic corneas found no statistically significant difference between the groups. Since diabetes may damage the inner layer of the cornea, other variables that affect cell health must also be evaluated.

Targeting of Myo/Nog cells using a novel nanocarrier complex loaded with doxorubicin is showing promise as a treatment for reducing posterior capsule opacification.

Combination treatment with squalamine lactate ophthalmic solution 0.2% and ranibizumab PRN resulted in improved visual function in patients with neovascular age-related macular degeneration compared with treatment with ranibizumab alone.

Find out how to improve your surgical work flow, reducing the total phaco time and total amount of fluid in cataract procedures while you stay very safe and efficient.

Tell Ophthalmology Times what areas you wish we covered more by taking this short survey.

Dr. McDonald advises taking a second visit to an established dry eye center of excellence a few months after your first visit. Begin by implementing the osmolarity units, train staff, and promote that your office is now a center of dry eye excellence. Watch more on how to be successful!”

While many people across the United States are hosting barbeques, attending parades and firework displays, and picnicking with their families today, ophthalmologists may find themselves celebrating Independence Day a little differently-handling emergencies due to firework-related eye injuries.

The first case series report of femtosecond laser flap creation for LASIK in eyes that have undergone radial keratotomy showed the technique was successful when novel settings were used. No significant intraoperative or postoperative complications were reported in the 27 eyes in the study, and uncorrected visual acuity improved significantly.

Patients with symptomatic vitreomacular adhesion (VMA) find that a single intravitreal injection of ocriplasmin improves their vision, according to an ancillary analysis of two multicentre randomised clinical trials reported in JAMA Opthalmology.